EMA – Open consultation: Addendum to the Guideline on clinical development of vaccines to address clinical trials in immunocompromised individuals
Year: 2024
Type: other
Abstract: This Addendum to the guideline provides guidance on clinical studies to be conducted in immunocompromised individuals before or after initial marketing authorization of vaccines in order to support recommendations for use in the Product Information. The deadline for the consultation is 31 October 2024. More open consultations on the EMA Website.
Source: OpenEdition (OpenEdition)
DOI: 10.58079/12j9t
Author: Vroby
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6918065245
Cites:
Cited by:
Related to: